# FDA Inspection 815230 - CSL Plasma, Inc. - January 24, 2013

Source: https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/00fe0427-eb18-4e9b-a12a-7e2b5bd4e17d
Source feed: FDA_Inspections

> FDA Inspection 815230 for CSL Plasma, Inc. on January 24, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 815230
- Company Name: CSL Plasma, Inc.
- Inspection Date: 2013-01-24
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1210732 - 2023-06-27](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/1db3b154-8c0f-40a7-a29b-c4ff387ac9a0)
- [FDA Inspection 1039861 - 2017-12-07](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/99576527-f027-4fe5-aaf0-7d6acd1dacfa)
- [FDA Inspection 715605 - 2011-02-23](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/8a44e73f-dc7e-451e-903c-a4439c048a2a)

Company: https://www.keypedia.com/companies/csl-plasma-inc/afc3f94b-05cb-43d8-9327-670b3c60037b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d